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 Introduction 
 Takayasu arteritis (TA) is a rare, chronic, systemic, 
inflammatory vasculitis that involves large- and medi-
um-sized vessels  [1, 2] . It predominantly occurs in fe-
males and its etiology is unknown  [1] . The clinical pre-
sentation of TA varies according to the localization and 
the extent of the involved vessels  [1] . Therefore, different 
clinical symptoms may be seen, ranging from fever and 
malaise to hypertension and ischemic symptoms, such as 
claudication and angina. Pulses are commonly absent in 
the involved vessels, particularly in the subclavian artery 
 [1, 2] . According to histopathological investigations, the 
histologic characteristic of TA is a cell-mediated autoim-
mune disorder associated with cellular infiltration of the 
macrophages and CD4+ and CD8+ T cells  [3, 4] . TA has 
2 phases: early systemic phase and late phase. Nonspe-
cific acute inflammatory features are found in the early 
systemic phase, which is characterized by the involve-
ment of the adventitial vasa vasorum and the cellular in-
filtration of the tunica media  [5, 6] . Intimal hyperplasia 
occurs due to the fibrosis of the tunica media and intima 
during this period. The late phase is characterized by the 
destruction of the elastic tissue and marked fibrosis, 
which leads to stenosis, occlusion, or aneurysm in the 
artery  [5, 7] .
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 Abstract 
 Objectives: To investigate the association between endothe-
lial progenitor cells  (EPCs) and Takayasu arteritis (TA).  Sub-
jects and  Methods: A total of 39 subjects were included in 
this study: 12 subjects had been diagnosed with active TA, 11 
had active Behçet disease (BD), and 16 were healthy controls. 
The EPCs, erythrocyte sedimentation rate (ESR), and C-reac-
tive protein (CRP) levels of all the subjects were measured. 
MedCalc 15.8 software (MedCalc, Belgium) was used for all 
statistical analyses.  Results: The level of EPCs was higher in 
TA patients (4.25 ± 2.56) than in the BD group (2.27 ± 2.0) and 
the healthy controls (2.12 ± 1.2) ( p = 0.015). TA patients with 
acrotism (n = 4) had higher levels of EPCs compared to TA 
patients without acrotism ( n = 8) (6.50 ± 1.73 vs. 3.12 ± 2.16, 
 p = 0.02). A positive correlation was found between EPCs and 
the ESR ( r = 0.723,  p = 0.0079) and between EPCs and CRP in 
patients with TA ( r = 0.769,  p < 0.0034).  Conclusion: High lev-
els of circulating EPCs were correlated with the CRP level and 
the ESR in patients with TA. These cells could be a marker for 
acrotism and inflammation in patients with TA. 
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 Circulating endothelial progenitor cells (EPCs) are 
bone marrow-derived, immature cells that take part in 
neovascularization and vascular homeostasis; they are 
composed of several cell types, including hematopoietic 
and mesenchymal stem cells  [8] . The level of circulating 
EPCs is low in normal medical conditions, but rapidly 
increases in the case of vascular injury and tissue isch-
emia. In response to pathological stimulation resulting 
from vascular injury or tissue ischemia, the EPCs migrate 
to the peripheral circulation and develop into mature en-
dothelial cells  [9] . In this study, we aimed to investigate 
the association between EPCs and TA.
 Material and Methods 
 Study Design and Ethical Approval 
 This cross-sectional cohort study was carried out in the Rheu-
matology Clinics, Adana Training Hospital, Başkent University 
School of Medicine, Turkey, from March 5, 2011, to July 1, 2011. 
The Hospital Ethics Committee approved the study and written 
informed consent was obtained from all subjects. All procedures 
were in accordance with the Good Clinical Practice standards, the 
ethical standards of the Responsible Committee on Human Ex-
perimentation, and the Helsinki Declaration of 1975, as revised in 
2008.
 Population 
 A total of 39 subjects (13 males and 26 females), with a mini-
mum age of 18 years were included in this study. The study group 
consisted of 12 patients with active TA, and the control group con-
sisted of 16 healthy subjects. We also enrolled 11 patients with ac-
tive Behçet disease (BD) as a positive control group. Additionally, 
TA patients were divided into 2 subgroups according to the pres-
ence (n = 8) or absence (n = 4) of a pulse.
 The exclusion criteria were chronic diseases other than TA and 
BD; medical conditions that could cause inflammation or ischemia 
and effect EPC levels, such as malignancy, infections, recent sur-
gery, or trauma; and breastfeeding and pregnant women. The 
medical histories and conditions of the participants were carefully 
ascertained by physicians (Ş.O.K., E.D.E.-B., and A.E.Y.). Patients 
with TA fulfilled the proposed classification criteria of the Ameri-
can College of Rheumatology for TA  [10] . The disease activity of 
the patients with TA was assessed with Kerr’s criteria  [11] . Acro-
tism was defined as absence of a pulse in patients with TA (pulse-
lessness). The diagnosis of BD was based on new international cri-
teria  [12] . Activity of BD was determined according to the activity 
index of the Behçet’s Disease Research Committee of Japan  [13] .
 Blood Sample Collection and Analysis 
 A peripheral blood sample was drawn using a 21-gauge needle 
into a tube containing ethylenediaminetetraacetic acid (EDTA) as 
an anticoagulant. The blood samples were kept at 4  °  C and analyzed 
using flow cytometry within 4 h of venesection. Peripheral whole 
blood cells were prepared by a lyse/wash procedure and were then 
evaluated using a flow cytometer (FACSCantoII; Becton Dickin-
son, San Jose, CA, USA). The use of this procedure minimizes cell 
loss, making it possible to measure all EPCs in the blood samples. 
A multistep manual technique was used to detect and quantify 
EPCs. An assessment of a minimum of 400,000 cells/peripheral 
blood sample was considered informative. Anti-CD146 PE, anti-
CD31 FITC, anti-CD45 APC- Cy7, and anti-CD34 PE- Cy7 mono-
clonal antibodies were used for the detection of EPCs. All mono-
clonal antibodies were from Becton Dickinson BioScience (San 
Jose, California, USA). The Cell-Dyn 3700 Hematology Analyzer 
(Abbott Laboratories, Chicago, IL, USA) was used for white blood 
cell counts. Cells were identified as EPCs if they were CD146+/
CD31+/CD45–/CD34+ cells ( Fig. 1 ). Flow cytometry data were an-
alyzed with DIVA software (Becton Dickinson). Nonviable cells, 
platelets, debris, and nonspecific binding were excluded from the 
analysis by isotopic control and consecutive gating  [14, 15] .
 The ESR and CRP were measured in all patients and the levels 
were determined using the Westergreen method and immunotur-
bidimetry, respectively.
 Statistical Analysis 
 MedCalc 15.8 software (MedCalc, Ostend, Belgium) was used 
for all statistical analyses, and the data are reported as means ± SD. 
The Kolmogorov-Smirnov test was used to show the normal dis-
tribution of quantitative measurements, a χ 2 test was used to test 
the statistical significance of the differences in frequencies, and 
ANOVA or Kruskal-Wallis tests were used for the comparison of 
the quantitative measurements (EPCs, ESR, CRP, and age) be-
tween more than 2 groups. A post hoc test (using Student-New-
man-Keuls) was performed for pairwise comparison of subgroups 
when the ANOVA test was positive ( p less than the selected sig-
nificance level).
 A Student  t test was used for the comparison of the quantitative 
measurements (disease duration) between the TA and BD groups. 
Additionally, a  t test was performed for the comparison of the sub-
groups (TA patients with or without a pulse) according to the 
EPCs, CRP, and ESR. The correlation coefficient was used to ana-
lyze the degree of association between the EPCs and CRP, and be-
tween EPCs and ESR (Pearson correlation coefficient ( r ) with  p 
value and 95% CI for  r ). Multiple regression analysis (backward 
method) was used to analyze the relationship between a dependent 
variable (EPCs) and 1 or more independent variables (age, sex, 
smoking status, disease duration, CRP, and ESR). According to the 
backward method, the model enters all variables into the model 
and then removes the nonsignificant variables sequentially. Age, 
sex, smoking status, disease duration, and CRP were not included 
in the model due to the very low tolerance of the variables (<0.0001). 
Power analysis was performed for the sample size to have 80% 
power with 5% type 1 error.
 The probability of making a type I error (α, significance) is 0.05 
in all tests.
 Results 
 The mean age of all the subjects was 32.8 ± 8.0 years. 
The mean ages of the TA, BD, and healthy groups were 
32.7 ± 6.5, 31.9 ± 8.5, and 33.6 ± 9.0 years, respectively
( p = 0.866). The clinical manifestations of the groups
are shown in  Table 1 while the distribution of vascular
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 Fig. 1. Analysis strategy for the identification of circulating endo-
thelial cells by using flow cytometry: immunophenotyping of FSC-
H and FSC-A ( a ), FSC-H and FSC-A ( b ), SSC-A and CD146 PE-A 
( c ), SSC-A and CD31 FITC-A ( d ), SSC-A and CD45 APC-Cy7-A 
( e ), and SSC-A and CD34 PE-Cy7-A ( f ). Gating and quantification 
of endothelial cells (nonviable cells, platelets, debris, and nonspe-
cific binding) were excluded in  a and  b . FSC-H, forward scatter 
height; FSC-A, forward scatter area; SSC-A, side scatter area; PE-
A, phycoerythrin area; FITC-A, fluorescein isothiocyanate area; 
APC-Cy7-A, allophycocyanin-cyanin7; PE-Cy7-A, phycoerythrin 
area. 
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involvement in TA patients is shown in  Table 2 . Demo-
graphic characteristics and biochemical measurements of 
the groups are shown in  Table 3 . The mean EPC levels 
were 4.25 ± 2.56 cells/μL in the patients with TA, 2.27 ± 
2.0 cells/μL in the patients with BD, and 2.12 ± 1.2 cells/
μL in the healthy subjects. The EPC levels were higher in 
patients with TA and the difference was statistically sig-
nificant ( p = 0.015;  Table 3 ).
 The mean levels of ESR were 20.7 ± 14.9 mm/h (TA), 
15.6 ± 12.6 mm/h (BD), and 9.1 ± 3.7 mm/h (healthy). 
Similarly, the mean ESRs of the groups were statistically 
different ( p = 0.028). Patients with TA had the highest 
ESR measurements. 
 The CRP levels of the TA, BD, and healthy groups were 
5.1 ± 3.5, 7.3 ± 10.6, and 1.0 ± 0.3 mg/L, respectively. The 
difference was statistically significant ( p = 0.001). The dis-
ease durations of the TA group and the BD group were 
comparable (73.7 ± 67.2 months vs. 31.1 ± 19.7 months; 
 p = 0.056).
 TA patients with acrotism (n = 4) had higher EPCs 
compared to TA patients with a palpable pulse (n = 8) 
(6.50 ± 1.73 vs. 3.12 ± 2.16 cells/μL,  p = 0.02). Addition-
ally, ESR and CRP levels were also higher in TA patients 
with acrotism (ESR: 36.0 ± 14.4 vs. 13.1 ± 7.7 mm/h,  p = 
0.004; CRP: 7.9 ± 5.1 vs. 3.8 ± 1.6 mg/L,  p = 0.012;  Table 4 ).
 According to the Pearson correlation analyses, a posi-
tive correlation was found between EPCs and ESR ( r = 
0.723,  p = 0.0079) and between EPCs and CRP in patients 
with TA ( r = 0.769,  p < 0.0034), while there was no cor-
relation in BD patients ( r = 0.110,  p = 0.746;  r = 0.200,
 p = 0.554, respectively). The correlations between EPCs, 
ESR, and CRP in the TA patients are shown in  Figure 2 .
 Table 1.  Clinical characteristic of the groups
Clinical manifestations TA
(n = 12)
BD
(n = 11)
Healthy
(n = 16)
Hypertension 8 (66.6) 3 (27.7) –
Malaise 7 (58.3) 5 (45.4) –
Claudication 5 (41.6) – –
Acrotism 4 (33.3) – –
Bruits 4 (33) 1 (9) –
Arthralgia 4 (33) 5 (45.4) –
Absence of blood pressure 3 (25) – –
Central nervous system 3 (25) 2 (18.1) –
Cutaneous 2 (16.6) 1 (9) –
Angina pectoris 1 (8.3) – –
Ocular involvement 1 (8.3) 4 (36.3) –
 Data are presented as n (%). TA, Takayasu arteritis; BD, Behçet 
disease.
 Table 2.  Vascular involvement of patients with TA
Vascular involvement n (%)
Left carotid artery 6 (50)
Left subclavian artery 5 (41.6)
Right carotid artery 4 (33.3)
Right subclavian artery 1 (8.3)
Descending aorta 1 (8.3)
Ascending aorta 1 (8.3)
Abdominal aorta 1 (8.3)
Thoracic aorta 1 (8.3)
Pulmonary artery 1 (8.3)
Brachial artery 1 (8.3)
Left renal artery 1 (8.3)
Right renal artery 1 (8.3)
Right coronary artery 1 (8.3)
 Table 3.  Comparison of the groups according to the demographic data and biochemical measures
TA
(n = 12)
BD
(n = 11)
Healthy subjects
(n = 16)
p values
Age, years 32.7 ± 6.5 (30.0) 31.9 ± 8.5 (30.0) 33.6 ± 9.0 (31.5) 0.866
Female 10 (83.3) 7 (63.6) 9 (56.2) 0.799
Smoking 2 (16.7) 2 (18.2) 4 (25.0) 0.893
ESR, mm/h 20.7 ± 14.9 (16.5) 15.6 ± 12.6 (10.0) 9.1 ± 3.7 (8.5) 0.028
CRP, mg/L 5.1 ± 3.5 (3.9) 7.3 ± 10.6 (3.0) 1.0 ± 0.3 (1.0) <0.001
EPCs, cells/μL 4.25 ± 2.56 (4.0) 2.27 ± 2.0 (2.0) 2.12 ± 1.2 (2.0) 0.015
Disease duration, months 73.7 ± 67.2 (60.5) 31.1 ± 19.7 (40.0) – 0.056
Data are presented as means ± SD (median) or n (%). TA, Takayasu arteritis; BD, Behçet disease.
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 Multiple regression analysis (backward method) was 
performed with EPCs as a dependent variable and with 
age, sex, smoking status, disease duration, ESR, and CRP 
as independent variables. ESR was independently associ-
ated with EPC levels in TA patients ( p = 0.007).
 Discussion 
 In this study, patients with TA had high levels of EPCs 
and a positive correlation between EPCs and ESR, and 
between EPCs and CRP. Moreover, the EPC levels of the 
TA patients with acrotism were higher than without  acro-
tism. The association between EPCs and other rheumatic 
diseases, such as rheumatoid arthritis, systemic lupus er-
ythematosus, systemic sclerosis, and BD, has been inves-
tigated in previous studies. Low levels of EPCs were re-
ported in these studies  [16–19] . On the other hand, the 
association between EPCs and TA was investigated only 
in a few studies and high levels of EPCs were reported by 
them  [20, 21] . Dogan et al. [21] reported high levels of 
EPCs in active TA patients. In this study they compared 
active TA patients with inactive TA patients and healthy 
controls. In another study, Dang et al. [20] concluded that 
circulating endothelial cells were significantly higher in 
patients with aortoarteritis at active stages than in those 
at inactive stages. However, this study was not controlled 
and EPCs were not studied. Additionally, neither study 
investigated the association between EPCs and acrotism 
in TA patients.
 The high levels of EPCs in TA patients with acrotism 
could be due to ischemia caused by stenosis or occlusion; 
otherwise, the level of circulating EPCs is generally low in 
normal medical conditions, but rapidly increases in the 
case of vascular injury and tissue ischemia  [8, 9] . It has 
been shown that development of vessel wall inflamma-
tion due to the lymphocytic infiltration in the early phase 
and destruction of elastic tissue during the late phase  [22] 
of the disease leads to stenosis, occlusion, dilatation, and 
aneurism in TA patients  [6, 7] .
 In the present study, EPC levels were high in TA pa-
tients compared to BD patients. BD is both a systemic 
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 Table 4.  Comparisons between TA patients with or without pulselessness
TA patients with acrotism
(n = 4)
TA patients without
acrotism (n = 8)
p
Age, years 34.2 ± 6.8 (33.5) 32.0 ± 6.7 (30.0) 0.594
Female 4 (100) 5 (62.5) 0.490
Smoking 1 (25) 1 (12.5) 0.625
ESR, mm/h 36.0 ± 14.4 (31) 13.1 ± 7.7 (11) 0.004
CRP, mg/L 7.9 ± 5.1 (7.7) 3.8 ± 1.6 (3.7) 0.012
EPCs, cells/μL 6.50 ± 1.73 (6.5) 3.12 ± 2.16 (3.5) 0.02
Disease duration, months 56.8 ± 43.3 (65.0) 107.5 ± 99.5 (47.5) 0.233
Data are presented as means ± SD (median) or n (%). TA, Takayasu arteritis.
 Fig. 2. Comparison of EPCs, ESR, and CRP. The horizontal axis 
shows the EPCs (cells/μL) levels while the vertical axis shows the 
ESR (mm/h) and CRP (mg/L) levels for each case, sequentially. 
The correlation between EPCs and ESR, and between EPCs and 
CRP, can be seen more clearly in this figure. 
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vasculitis and chronic inflammatory disease, as is TA 
 [23] . However, high EPC levels in TA patients may be 
associated with specific factors related with the histopa-
thology of TA that are different from BD. TA is a pro-
gressive form of vasculitis with ongoing inflammation. 
Endothelial injury and endothelial repair occur in com-
bination  [21] . EPCs increase in case of ongoing or acute 
inflammation while they decrease in case of chronic in-
flammatory state  [24, 25] . Further reinforcing this link, 
Fadini et al. [19] reported low levels of EPC in patients 
with BD in their study. In another study, Bozkirli et al. 
[26] studied EPCs in BD patients and reported that the 
levels of EPCs were not high compared to levels in the 
healthy controls.
 The CRP and ESR levels of TA patients were higher 
compared to healthy controls in the present study. More-
over, they were positively correlated with EPCs levels in 
TA patients. In accordance with this link, Dang et al. [20] 
reported a positive correlation between circulating endo-
thelial cells and ESRs in active aortoarteritis patients. Ad-
ditionally, Dogan et al.  [21]  reported a positive correla-
tion between EPCs and Indian Takayasu Activity Score 
CRP levels in active TA patients. The progressive form of 
vasculitis with ongoing inflammation that results in ves-
sel injury can lead to high levels of CRP and ESR  [21] . 
CRP plays a role in mediating vascular disease and acti-
vates the classical complement signaling cascade, which 
plays a key role in neointima formation in injured vessels 
 [27] . Additionally, we have reported higher levels of CRP 
and ESR in TA patients with acrotism. This result might 
occur due to the increased vessel inflammation in TA pa-
tients with acrotism.
 This study had some limitations. First, vascular endo-
thelial growth factor receptor-2 was not used to charac-
terize EPCs because it is restricted to endothelial cells and 
their progenitors. Second, both TA and BD patients were 
receiving treatment during the study period so EPC levels 
might be affected. Fourth, due to the study design (cross-
sectional cohort), EPCs levels were measured only once 
and they were not measured after a period of treatment.
 Conclusion 
 In this study, patients with TA had high levels of EPCs. 
The TA patients with acrotism had higher levels of EPCs 
than those without. The EPCs were correlated with acute 
phase reactants. These findings indicate that EPCs could 
provide information about vascular involvement in pa-
tients with TA, in particular for patients with the absence 
of a pulse. EPCs might also show acute inflammation and 
active disease in patients with TA.
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